After a year as COO of K-Scale Labs, Rui Xu reflects on the hard lessons behind the collapse of its low-cost humanoid robot ambitions.
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...